Abstract
Objectives
The aim of this study is to investigate the expression of sTREM-1 and its ligand PGLYRP1, as well as the expression of MMP-8 and its inhibitor TIMP-1, in peri-implant diseases. As a secondary aim, we analyzed the influence of the concomitant existence of periodontitis in the expression of these biomarkers.
Materials and methods
This study included 77 patients (29 males and 48 females; mean age 55.0 ± 11.5), 18 having gingivitis, 16 having periodontitis, 20 having mucositis, and 23 having peri-implantitis. Patients were clinically examined, and unstimulated whole saliva was collected. sTREM-1, PGLYRP1, MMP-8, TIMP-1, and MMP-8/TIMP1 ratio were determined by ELISA.
Results
The periodontitis group presented higher probing depth (PD) mean, and higher clinical attachment loss, compared with the other groups. The peri-implantitis group presented higher PD mean in implants compared to the mucositis group. Patients with PD ≥ 6 mm showed significantly higher levels of PGLYRP1, MMP-8, and MMP-8/TIMP-1 ratio than patients with PD < 6 mm. When all four markers were assessed, there were no significant differences between mucositis and peri-implantitis groups. Concomitant periodontitis resulted in higher significant levels of MMP-8 in patients with peri-implant disease.
Conclusion
We did not observe significant differences in the levels of the sTREM-1/PGLYRP1/MMP-8 axis between patients with periodontal and peri-implant diseases, suggesting that these markers are also involved in the inflammatory process around implants. Besides, the presence of periodontitis may affect the levels of MMP-8 in patients with peri-implant disease.
Clinical relevance
The sTREM-1/PGLYRP1/MMP-8 axis could be useful as potent markers in periodontal and peri-implant diseases.
Similar content being viewed by others
References
Zitzmann NU, Berglundh T (2008) Definition and prevalence of peri-implant diseases. J Clin Periodontol 35(8):286–291. https://doi.org/10.1111/j.1600-051X.2008.01274.x
Heitz-Mayfield LJ, Lang NP (2010) Comparative biology of chronic and aggressive periodontitis vs. peri-implantitis. Periodontol 2000 53:167–181. https://doi.org/10.1111/j.1600-0757.2010.00348.x
Renvert S, Polyzois I (2015) Risk indicators for peri-implant mucositis: a systematic literature review. J Clin Periodontol 42(16):172–186. https://doi.org/10.1111/jcpe.12346
Berglundh T, Zitzmann NU, Donati M (2011) Are peri-implantitis lesions different from periodontitis lesions? J Clin Periodontol 38(11):188–202. https://doi.org/10.1111/j.1600-051X.2010.01672.x
Salvi GE, Cosgarea R, Sculean A (2017) Prevalence and mechanisms of Peri-implant diseases. J Dent Res 96(1):31–37. https://doi.org/10.1177/0022034516667484
Bouchon A, Dietrich J, Colonna M (2000) Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 15(164):4991–4995
Bleharski JR, Kiessler V, Buonsanti C, Sieling PA, Stenger S, Colonna M, Modlin RL (2003) A role for triggering receptor expressed on myeloid cells-1 in host defence during the early-induced and adaptive phases of the immune response. J Immunol 1(170):3812–3818
Bostanci N, Belibasakis GN (2012) Doxycycline inhibits TREM-1 induction by Porphyromonas gingivalis. FEMS Immunol Med Microbiol 66(1):37–44. https://doi.org/10.1111/j.1574-695X.2012.00982.x
Bostanci N, Thurnheer T, Belibasakis GN (2011) Involvement of the TREM-1/DAP12 pathway in the innate immune responses to Porphyromonas gingivalis. Mol Immunol 49(1–2):387–394. https://doi.org/10.1016/j.molimm.2011.09.012
Gibot S, Kolopp-Sarda MN, Béné MC, Bollaert PE, Lozniewski A, Mory F, Levy B, Faure GC (2004) A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med 6(11):1419–1426
Bostanci N, Thurnheer T, Aduse-Opoku J, Curtis MA, Zinkernagel AS, Belibasakis GN (2013) Porphyromonas gingivalis regulates TREM-1 in human polymorphonuclear neutrophils via its gingipains. PLoS One 4(10):e75784. https://doi.org/10.1371/journal.pone.0075784
Gómez-Piña V, Soares-Schanoski A, Rodríguez-Rojas A, Del Fresno C, García F, Vallejo-Cremades MT, Fernández-Ruiz I, Arnalich F, Fuentes-Prior P, López-Collazo E (2007) Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J Immunol 179:4065–4073
Weiss G, Lai C, Fife ME, Grabiec AM, Tildy B, Snelgrove RJ, Xin G, Lloyd CM, Hussell T (2017) Reversal of TREM-1 ectodomain shedding and improved bacterial clearance by intranasal metalloproteinase inhibitors. Mucosal Immunol 10(4):1021–1030. https://doi.org/10.1038/mi.2016.104
Su L, Liu C, Li C, Jiang Z, Xiao K, Zhang X, Li M, Yan P, Feng D, Xie L (2012) Dynamic changes in serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and its gene polymorphisms are associated with sepsis prognosis. Inflammation 35(6):1833–1843. https://doi.org/10.1007/s10753-012-9504-z
Bostanci N, Oztürk VÖ, Emingil G, Belibasakis GN (2013) Elevated oral and systemic levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in periodontitis. J Dent Res 92(2):161–165
Nylund KM, Ruokonen H, Sorsa T, Heikkinen AM, Meurman JH, Ortiz F, Tervahartiala T, Furuholm J, Bostanci N (2017) Association of the salivary triggering receptor expressed on myeloid cells/ its ligand peptidoglycan recognition protein 1 axis with oral inflammation in kidney disease. J Periodontol 28:1–17. https://doi.org/10.1902/jop.2017.170218
Belibasakis GN, Öztürk VÖ, Emingil G, Bostanci N (2014) Soluble triggering receptor expressed on myeloid cells 1 (sTREM-1) in gingival crevicular fluid: association with clinical and microbiologic parameters. J Periodontol 85(1):204–210. https://doi.org/10.1902/jop.2013.130144
Willi M, Belibasakis GN, Bostanci N (2014) Expression and regulation of triggering receptor expressed on myeloid cells 1 in periodontal diseases. Clin Exp Immunol 178(1):190–200. https://doi.org/10.1111/cei.12397
Read CB, Kuijper JL, Hjorth SA, Heipel MD, Tang X, Fleetwood AJ, Dantzler JL, Grell SN, Kastrup J, Wang C, Brandt CS, Hansen AJ, Wagtmann NR, Xu W, Stennicke VW (2015) Cutting edge: identification of neutrophil PGLYRP1 as a ligand for TREM-1. J Immunol 15(4):1417–1421. https://doi.org/10.4049/jimmunol.1402303
Dziarski R, Gupta D (2010) Review: mammalian peptidoglycan recognition proteins (PGRPs) in innate immunity. Innate Immun 16(3):168–174. https://doi.org/10.1177/1753425910366059
Silbereisen A, Hallak AK, Nascimento GG, Sorsa T, Belibasakis GN, Lopez R, Bostanci N (2019) Regulation of PGLYRP1 and TREM-1 during progression and resolution of gingival inflammation. JDR Clin Trans Res 23:2380084419844937. https://doi.org/10.1177/2380084419844937
Brownell NK, Khera A, de Lemos JA, Ayers CR, Rohatgi A (2016) Association between peptidoglycan recognition protein-1 and incident atherosclerotic cardiovascular disease events: the Dallas heart study. J Am Coll Cardiol 67(19):2310–2312. https://doi.org/10.1016/j.jacc.2016.02.063
Teixeira MKS, Lira-Junior R, Telles DM, Lourenço EJV, Figueredo CM (2017) Th17-related cytokines in mucositis: is there any difference between peri-implantitis and periodontitis patients? Clin Oral Implants Res 28(7):816–822. https://doi.org/10.1111/clr.12886
Armitage GC (1999) Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4:1–6
Berglundh T, Armitage G, Araujo MG, Avila-Ortiz G, Blanco J, Camargo PM, Chen S, Cochran D, Derks J, Figuero E, Hämmerle CHF, Heitz-Mayfield LJA, Huynh-Ba G, Iacono V, Koo KT, Lambert F, McCauley L, Quirynen M, Renvert S, Salvi GE, Schwarz F, Tarnow D, Tomasi C, Wang HL, Zitzmann N (2018) Peri-implant diseases and conditions: consensus report of workgroup 4 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol 89(l):S313–S318. https://doi.org/10.1038/sj.bdj.2018.617
Lindhe J, Meyle J (2008) Peri-implant diseases: consensus report of the sixth European workshop on periodontology. J Clin Periodontol 35:282–285. https://doi.org/10.1111/j.1600-051X.2008.01283.x
Nylund KM, Meurman JH, Heikkinen AM, Honkanen E, Vesterinen M, Furuholm JO, Tervahartiala T, Sorsa T, Ruokonen HM (2015) Periodontal inflammatory burden and salivary matrix metalloproteinase-8 concentration among patients with chronic kidney disease at the predialysis stage. J Periodontol 86(11):1212–1220. https://doi.org/10.1902/jop.2015.150285
Mauramo M, Ramseier AM, Mauramo E, Buser A, Tervahartiala T, Sorsa T, Waltimo T (2018) Associations of oral fluid MMP-8 with periodontitis in Swiss adult subjects. Oral Dis 24(3):449–455. https://doi.org/10.1111/odi.12769
Öztürk VÖ, Belibasakis GN, Emingil G, Bostanci N (2016) Impact of aging on TREM-1 responses in the periodontium: a cross-sectional study in an elderly population. BMC Infect Dis 19(1):429. https://doi.org/10.1186/s12879-016-1778-6
Hajishengallis G (2014) Aging and its impact on innate immunity and inflammation: implications for periodontitis. J Oral Biosci 1(1):30–37
Fortin CF, Lesur O, Fulop T Jr (2007) Effects of aging on triggering receptor expressed on myeloid cells (TREM)-1-induced PMN functions. FEBS Lett 20(6):1173–1178. https://doi.org/10.1016/j.febslet.2007.02.029
Ziebolz D, Schmalz G, Gollasch D, Eickholz P, Rinke S (2017) Microbiological and aMMP-8 findings depending on peri-implant disease in patients undergoing supportive implant therapy. Diagn Microbiol Infect Dis 88(1):47–52. https://doi.org/10.1016/j.diagmicrobio.2017.02.008
Wang HL, Garaicoa-Pazmino C, Collins A, Ong HS, Chudri R, Giannobile WV (2016) Protein biomarkers and microbial profiles in peri-implantitis. Clin Oral Implants Res 27(9):1129–1136. https://doi.org/10.1111/clr.12708
Kivelä-Rajamäki MJ, Teronen OP, Maisi P, Husa V, Tervahartiala TI, Pirilä EM, Salo TA, Mellanen L, Sorsa TA (2003a) Laminin-5 gamma2-chain and collagenase-2 (MMP-8) in human peri-implant sulcular fluid. Clin Oral Implants Res 14(2):158–165
Kivelä-Rajamäki M, Maisi P, Srinivas R, Tervahartiala T, Teronen O, Husa V, Salo T, Sorsa T (2003b) Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid. J Periodontal Res 38(6):583–590
Proctor GB (2016) The physiology of salivary secretion. Periodontol 70(1):11–25
Belibasakis GN, Charalampakis G, Bostanci N, Stadlinger B (2015) Peri-implant infections of oral biofilm etiology. Adv Exp Med Biol 830:69–84. https://doi.org/10.1007/978-3-319-11038-7_4
Jaedicke KM, Preshaw PM, Taylor JJ (2016) Salivary cytokines as biomarkers of periodontal diseases. Periodontol 2000 70(1):164–183. https://doi.org/10.1111/prd.12117
Kasuma N, Oenzil F, Darwin E, Sofyan Y (2018) The analysis of matrix metalloproteinase-8 in gingival crevicular fluid and periodontal diseases. Indian J Dent Res 29(4):450–454. https://doi.org/10.4103/ijdr.IJDR_97_15
Nędzi-Góra M, Górska R, Kostrzewa-Janicka J, Kowalski J (2017) Concentration of MMP-8 and IL-1β in gingival crevicular fluid in patients with chronic and aggressive periodontitis. Cent Eur J Immunol 42(4):342–346. https://doi.org/10.5114/ceji.2017.72824
Zhang L, Li X, Yan H, Huang L (2018) Salivary matrix metalloproteinase (MMP)-8 as a biomarker for periodontitis: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 97(3):e9642. https://doi.org/10.1097/MD.0000000000009642
Ramseier CA, Eick S, Brönnimann C, Buser D, Brägger U, Salvi GE (2016) Host-derived biomarkers at teeth and implants in partially edentulous patients. A 10-year retrospective study. Clin Oral Implants Res 27(2):211–217. https://doi.org/10.1111/clr.12566
Al-Majid A, Alassiri S, Rathnayake N, Tervahartiala T, Gieselmann DR, Sorsa T (2018) Matrix metalloproteinase-8 as an inflammatory and prevention biomarker in periodontal and peri-implant diseases. Int J Dent 16(2018):7891323–7891327. https://doi.org/10.1155/2018/7891323
Nomura T, Ishii A, Shimizu H, Taguchi N, Yoshie H, Kusakari H, Hara K (2000) Tissue inhibitor of metalloproteinases-1, matrix metalloproteinases-1 and -8, and collagenase activity levels in peri-implant crevicular fluid after implantation. Clin Oral Implants Res 11(5):430–440
Äyräväinen L, Heikkinen AM, Kuuliala A, Ahola K, Koivuniemi R, Moilanen E, Hämäläinen M, Tervahartiala T, Meurman JH, Leirisalo-Repo M, Sorsa T (2018) Anti-rheumatic medication and salivary MMP-8, a biomarker for periodontal disease. Oral Dis 24(8):1562–1571. https://doi.org/10.1111/odi.12930
Thierbach R, Maier K, Sorsa T, Mäntylä P (2016) Peri-implant sulcus fluid (PISF) matrix metalloproteinase (MMP)-8 levels in peri-implantitis. J Clin Diagn Res 10(5):ZC34–ZC38. https://doi.org/10.7860/JCDR/2016/16105.7749
Owen CA, Hu Z, Lopez-Otin C, Shapiro SD (2004) Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue-inhibitor of metalloproteinase-resistant collagenase and serpinase. J Immunol 172:7791–7803
Pugin J, Widmer MC, Kossodo S, Liang CM, Preas HL 2nd, Suffredini AF (1999) Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am J Respir Cell Mol Biol 20:458–464
Delclaux C, Delacourt C, d’Ortho MP, Boyer V, Lafuma C, Harf A (1996) Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 14:288–295
Funding
The authors have no funding to declare.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The study was approved by the Ethics Committee of the Pedro Ernesto University Hospital (No 857.118).
Informed consent
All participants signed informed consent. All procedures performed in the study were following the 1964 Helsinki declaration and its later amendments.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Teixeira, M.K.S., Lira-Junior, R., Lourenço, E.J.V. et al. The modulation of the TREM-1/PGLYRP1/MMP-8 axis in peri-implant diseases. Clin Oral Invest 24, 1837–1844 (2020). https://doi.org/10.1007/s00784-019-03047-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-019-03047-z